5AM Venture Management

Latest statistics and disclosures from 5AM Venture Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for 5AM Venture Management

5AM Venture Management holds 28 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Entrada Therapeutics (TRDA) 14.6 $70M 4.4M 15.98
 View chart
Enliven Therapeutics (ELVN) 9.2 $45M -32% 1.8M 25.54
 View chart
Skye Bioscience Com New (SKYE) 8.0 $39M -2% 9.9M 3.91
 View chart
Artiva Biotherapeutics 7.5 $36M NEW 2.4M 15.45
 View chart
Dianthus Therapeutics (DNTH) 7.0 $34M 1.2M 27.38
 View chart
Biohaven (BHVN) 4.9 $24M 479k 49.97
 View chart
Tyra Biosciences (TYRA) 4.6 $22M 939k 23.51
 View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA) 4.2 $21M +3% 1.3M 15.99
 View chart
Tectonic Therapeutic (TECX) 4.0 $20M 647k 30.30
 View chart
Praxis Precision Medicines I Com New (PRAX) 4.0 $20M 340k 57.54
 View chart
Celldex Therapeutics Com New (CLDX) 3.5 $17M 497k 33.99
 View chart
Miragen Therapeutics (VRDN) 3.5 $17M 737k 22.75
 View chart
Viking Therapeutics (VKTX) 3.1 $15M 238k 63.31
 View chart
Pharvaris N V (PHVS) 3.1 $15M 798k 18.52
 View chart
Erasca (ERAS) 3.0 $15M 5.4M 2.73
 View chart
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.9 $14M 282k 50.42
 View chart
Anaptysbio Inc Common (ANAB) 2.5 $12M 358k 33.50
 View chart
Silence Therapeutics Ads (SLN) 1.8 $8.7M 476k 18.18
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 1.7 $8.4M +2000% 1.1M 7.99
 View chart
Cogent Biosciences (COGT) 1.3 $6.1M -28% 562k 10.80
 View chart
Scpharmaceuticals (SCPH) 1.1 $5.5M 1.2M 4.56
 View chart
Vor Biopharma (VOR) 0.9 $4.5M 6.4M 0.70
 View chart
Rallybio Corp (RLYB) 0.9 $4.2M 3.6M 1.17
 View chart
Gh Research Ordinary Shares (GHRS) 0.8 $3.8M 573k 6.69
 View chart
Adverum Biotechnologies Com New (ADVM) 0.8 $3.8M 542k 7.02
 View chart
Mersana Therapeutics (MRSN) 0.5 $2.5M 1.3M 1.89
 View chart
Zentalis Pharmaceuticals (ZNTL) 0.4 $1.8M 490k 3.68
 View chart
Cidara Therapeutics Com New (CDTX) 0.1 $610k 57k 10.75
 View chart

Past Filings by 5AM Venture Management

SEC 13F filings are viewable for 5AM Venture Management going back to 2019

View all past filings